Invention Grant
US09308201B2 Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
有权
包含7-（1H-咪唑-4-基甲基）-5,6,7,8-四氢 - 喹啉用于治疗皮肤疾病和病症的药物组合物
- Patent Title: Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
- Patent Title (中): 包含7-（1H-咪唑-4-基甲基）-5,6,7,8-四氢 - 喹啉用于治疗皮肤疾病和病症的药物组合物
-
Application No.: US14702219Application Date: 2015-05-01
-
Publication No.: US09308201B2Publication Date: 2016-04-12
- Inventor: Mohammed I. Dibas , Edward C. Hsia , John E. Donello , Daniel W. Gil
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Barbara C. Potts
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K9/00
Abstract:
The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-Imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
Information query
IPC分类:
